APA

Hu F., Li C., Zheng X., Zhang H., Shen Y., Zhou L., Yang X., Han B. & Zhang X. (20200821). Lung adenocarcinoma resistance to therapy with EGFR‑tyrosine kinase inhibitors is related to increased expression of cancer stem cell markers SOX2, OCT4 and NANOG. : Oncology reports.

Chicago

Hu Fang, Li Changhui, Zheng Xiaoxuan, Zhang Hai, Shen Yinchen, Zhou Lin, Yang Xiaohua, Han Baohui and Zhang Xueyan. 20200821. Lung adenocarcinoma resistance to therapy with EGFR‑tyrosine kinase inhibitors is related to increased expression of cancer stem cell markers SOX2, OCT4 and NANOG. : Oncology reports.

Harvard

Hu F., Li C., Zheng X., Zhang H., Shen Y., Zhou L., Yang X., Han B. and Zhang X. (20200821). Lung adenocarcinoma resistance to therapy with EGFR‑tyrosine kinase inhibitors is related to increased expression of cancer stem cell markers SOX2, OCT4 and NANOG. : Oncology reports.

MLA

Hu Fang, Li Changhui, Zheng Xiaoxuan, Zhang Hai, Shen Yinchen, Zhou Lin, Yang Xiaohua, Han Baohui and Zhang Xueyan. Lung adenocarcinoma resistance to therapy with EGFR‑tyrosine kinase inhibitors is related to increased expression of cancer stem cell markers SOX2, OCT4 and NANOG. : Oncology reports. 20200821.